SAG1.3-derived Frizzled-targeting small-molecule compounds.

Saved in:
Bibliographic Details
Title: SAG1.3-derived Frizzled-targeting small-molecule compounds.
Authors: Grätz L; Karolinska Institutet, Department Physiology & Pharmacology, Sec. Receptor Biology & Signaling, Biomedicum, Stockholm, Sweden., Turku A; Karolinska Institutet, Department Physiology & Pharmacology, Sec. Receptor Biology & Signaling, Biomedicum, Stockholm, Sweden., Kozielewicz P; Karolinska Institutet, Department Physiology & Pharmacology, Sec. Receptor Biology & Signaling, Biomedicum, Stockholm, Sweden., Bowin CF; Karolinska Institutet, Department Physiology & Pharmacology, Sec. Receptor Biology & Signaling, Biomedicum, Stockholm, Sweden., Scharf MM; Karolinska Institutet, Department Physiology & Pharmacology, Sec. Receptor Biology & Signaling, Biomedicum, Stockholm, Sweden., Voss JH; Karolinska Institutet, Department Physiology & Pharmacology, Sec. Receptor Biology & Signaling, Biomedicum, Stockholm, Sweden., Kinsolving J; Karolinska Institutet, Department Physiology & Pharmacology, Sec. Receptor Biology & Signaling, Biomedicum, Stockholm, Sweden., Shekhani R; Karolinska Institutet, Department Physiology & Pharmacology, Sec. Receptor Biology & Signaling, Biomedicum, Stockholm, Sweden., Oliva-Vilarnau N; Karolinska Institutet, Department Physiology & Pharmacology, Sec. Personalized Medicine and Drug Development, Biomedicum, Stockholm, Sweden., Koolmeister T; Chemical Biology Consortium Sweden, Science for Life Laboratory, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden., Körber M; Department of Chemistry and Pharmacy, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany., Lauschke VM; Karolinska Institutet, Department Physiology & Pharmacology, Sec. Personalized Medicine and Drug Development, Biomedicum, Stockholm, Sweden; Dr Margarete Fischer-Bosch Institute of Clinical Pharmacology, Translational Pharmacology and Drug Discovery, Stuttgart, Germany; University of Tübingen, Tübingen, Germany., Löber S; Department of Chemistry and Pharmacy, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany; FAUNeW - Research Center New Bioactive Compounds, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany., Gmeiner P; Department of Chemistry and Pharmacy, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany; FAUNeW - Research Center New Bioactive Compounds, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany., Schulte G; Karolinska Institutet, Department Physiology & Pharmacology, Sec. Receptor Biology & Signaling, Biomedicum, Stockholm, Sweden. Electronic address: gunnar.schulte@ki.se.
Source: The Journal of biological chemistry [J Biol Chem] 2025 Nov; Vol. 301 (11), pp. 110751. Date of Electronic Publication: 2025 Sep 22.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Inc. on behalf of American Society for Biochemistry and Molecular Biology Country of Publication: United States NLM ID: 2985121R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1083-351X (Electronic) Linking ISSN: 00219258 NLM ISO Abbreviation: J Biol Chem Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1083-351X
DOI:10.1016/j.jbc.2025.110751